Company Mera Pharmaceuticals, Inc. Other OTC
Equities
MRPI
US58732R1032
Biotechnology & Medical Research
Business Summary
Sales per Business
USD in Million | 2009 | Weight | 2010 | Weight | Delta |
---|---|---|---|---|---|
Natural Products
100.0
%
| 1 | 100.0 % | 0 | 100.0 % | -51.78% |
Sales per region
USD in Million | 2009 | Weight | 2010 | Weight | Delta |
---|---|---|---|---|---|
Global
100.0
%
| 1 | 100.0 % | 0 | 100.0 % | -51.78% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Benny Doro
PSD | President | 57 | 21-03-16 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Benny Doro
PSD | President | 57 | 21-03-16 |
Rafi Markarian
BRD | Director/Board Member | 60 | 21-03-16 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 0 | 974 | 0 | 0 | 99.91 % |
Stock B | 1 | 557,799,676 | 557,299,676 ( 99.91 %) | 500,000 ( 0.0896 %) | |
Stock C | 0 | 80 | 0 | 0 |
Company contact information
Mera Pharmaceuticals, Inc.
8275 South Eastern Avenue Suite 200
89123, Las Vegas
+
http://www.merapharma.comSector
1st Jan change | Capi. | |
---|---|---|
+1.51% | 42.75B | |
+49.22% | 41.61B | |
+8.57% | 41.34B | |
-12.36% | 26.59B | |
+8.92% | 25.49B | |
-25.13% | 18.12B | |
+29.17% | 12.24B | |
-3.12% | 11.76B | |
+6.35% | 11B |